Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer.
Pharmaceuticals (Basel)
; 13(11)2020 Nov 13.
Article
en En
| MEDLINE
| ID: mdl-33202977
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Pharmaceuticals (Basel)
Año:
2020
Tipo del documento:
Article
País de afiliación:
Estados Unidos